FDA Greenlights Eli Lilly's Foundayo Weight-Loss Pill
Irvine News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Federal regulators have approved Eli Lillys new weight-loss pill, Foundayo, a once-daily oral medication for obesity and related conditions. It mimics a hormone to curb hunger and boost fullness, with prices starting at $25 per month. Foundayo stands out for its small-molecule form and lack of dietary restrictions, unlike Novo Nordisks Wegovy. Trials showed improvements in waist size, blood pressure, and cholesterol levels, but gut side effects were significant. The approval aligns with the Trump administrations efforts to reduce GLP-1 drug costs, potentially increasing access to weight-loss treatments.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/d449914bf617dc76